United States Antimony Corporation

United States Antimony Corporation Earnings Recaps

UAMY Materials 3 recaps
Q1 2026 May 16, 2026

The stock declined 13.6% following the earnings release, driven by disappointing margin compression and weak sales performance in key segments, which overshadowed stable revenue and a cautious outlook on near-term cost pressures.

Key takeaways
  • First quarter sales remained nearly flat at $6.8 million versus $7 million last year, with the Antimony segment down 2% and Zeolite segment down 7%.
  • Gross profit declined by $1.3 million largely due to higher labor, factory, import, and freight costs incurred to support expected production ramp-up.
  • Net loss widened to $11.3 million, impacted by $4.8 million in noncash stock compensation and a $4.1 million unrealized loss on an equity investment.
  • Inventory increased by $9.5 million to $22 million as the company stockpiled resources ahead of anticipated growth.
  • The company remains well-capitalized with $60.2 million in cash and equivalents, plus recent capital raises and government grants, but operational cost pressures and slow sales momentum weighed heavily on investor sentiment.
Full recap
Q3 2026 May 15, 2026

Shares fell 4.0% as investors reacted negatively to margin compression driven by rising costs, flat sales, and a cautious tone on near-term profitability despite operational progress.

Key takeaways
  • Q1 sales were essentially flat at $6.8 million versus $7 million year-over-year, with antimony sales down 2% and zeolite sales down 7%.
  • Gross profit declined by $1.3 million due to higher labor, factory, import, and freight costs, which management attributed to investments in future production capacity.
  • Net loss widened to $11.3 million, largely reflecting $4.8 million in noncash stock compensation and a $4.1 million unrealized loss on equity investments.
  • Inventory increased significantly by $9.5 million to $22 million, indicating buildup for expected ramp-up later in the year.
  • The company highlighted progress in securing mining permits and government grants but did not commit to near-term earnings improvement, underscoring ongoing operational risk ahead.
Full recap
Q3 2025 Nov 13, 2025

United States Antimony Corporation reported a significant 182% year-over-year increase in sales for the first nine months of 2025, driven by price rises and improved production, though the company also incurred a net loss reflecting certain non-cash expenses.

Key takeaways
  • Consolidated sales reached $26.2 million for the first nine months, with a gross margin up to 28%, despite facing pressure from declining antimony prices.
  • Positive cash flow was generated from operating activities, excluding working capital adjustments, indicating improved financial health compared to the previous year.
  • The company significantly bolstered its cash position, ending Q3 with $38.5 million, primarily from warrant exercises and shares sales.
  • Secured a three-year antimony ore supply agreement and two major five-year sales contracts, strengthening revenue and supply chains.
  • Expanded mining claims and processing capabilities, enhancing its position as a vertically integrated player in the critical minerals market.
Full recap